Acta Vet. Brno 2023, 92: 279-287
https://doi.org/10.2754/avb202392030279
Feasible delivery system based on poly(lactictide-co-glycolide) nanoparticles loaded with antimicrobial mupirocin for possible wound healing
References
1. 2022: Prevalence and molecular characterization of methicilin-resistant Staphylococcus aureus from nasal specimens: Overcoming MRSA with silver nanoparticles and their applications. J Microbiol Biotechnol 32: 1-10
< AE, Gad el-Rab SMF, Halawani EM, Niaz AM, Bamaga MS https://doi.org/10.4014/jmb.2208.08004>
2. 2019: Development, characterization and pharmacokinetics of mupirocin-loaded nanostructured lipid carriers (NLCs) for intravascular administration. Int J Pharm 571: 118705
< KP, Zulfakar MH, Castillo AL https://doi.org/10.1016/j.ijpharm.2019.118705>
3. 2016: Comparative evaluation of antibacterial aktivity of caffeic acid phenethyl ester and PLGA nanoparticles formulation by different methods. Nanotechnology 27: 025103
< T, Derman S, Mansuroglu B https://doi.org/10.1088/0957-4484/27/2/025103>
4. 2006: Synthesis and characterization of PLGA nanoparticles. J Biomater Sci–Polym Ed 17: 247-289
< CE, Sabliov CM https://doi.org/10.1163/156856206775997322>
5. 2021: Topical delivery of heparin from PLGA nanoparticles entrapped in nanofibers of sericin/gelatin scaffolds for wound healing. Int J Pharm 597: 120207
< DDA, Gunduz U, Tezcaner A, Keskin D https://doi.org/10.1016/j.ijpharm.2021.120207>
6. 2017: Nanoparticle-based dressing: The future of wound treatment? Trends Biotechnol 35: 770-784
< M, Gauthier Y, Lacroix C, Verrier B, Monge C https://doi.org/10.1016/j.tibtech.2017.05.005>
7. 2022: Bacteriostatic and cytotoxic properties of composite material based on ZnO nanoparticles in PLGA obtained by low temperature method. Polymers 14: 49
< DE, Simakin AV, Smirnova VV, Uvarov OV, Ivashkin PI, Kucherov RN, Ivanov VE, Bruskov VI, Sevostyanov MA, Baikin AS, Kozlov VA, Rebezov MB, Semenova AA, Lisitsyn AB, Vedunova MV, Gudkov SV https://doi.org/10.3390/polym14010049>
8. 2021: Development of a dual delivery of levofloxacin and prednisolone acetate via PLGA nanoparticles/thermosensitive chitosan-based hydrogel for postoperative management: An in-vitro and ex-vivo study. Int J Biol Macromol 180: 365-374
< YH, Chang YF, Ko YC, Liu CJL https://doi.org/10.1016/j.ijbiomac.2021.03.017>
9. 2014: PLGA nanoparticles loaded with host defense peptide LL37 promote wound healing. J Control Release 194: 138-147
< KK, Her CH, Comune M, Moia C, Lopes A, Porporato PE, Vanacker J, Lam MC, Steinstraesser L, Sonveaux P, Huijun Z, Lino SF, Vandermeulen G, Préat V https://doi.org/10.1016/j.jconrel.2014.08.016>
10. 2021: Cytotoxicity of targeted PLGA nanoparticles: a systematic review. RCS Advances 11: 9433-9449
HI, Samad NA, Fang L, Lim V
11. 2019: Liposomal mupirocin holds promise for systemic treatment of invasive Staphylococcus aureus infections. J Control Release 316: 292-301
< O, Cern A, Musken M, Rohde M, Weiss W, Barenholz Y, Medina E https://doi.org/10.1016/j.jconrel.2019.11.007>
12. 2012: Antibacterial properties of nanoparticles. Trends Biotechnol 30: 499-511
< MJ, Fromm KM, Ashkarran AA, de Aberasturi DJ, de Larramendi, IR, Rojo T, Serpooshan V, Parak WJ, Mahmoudi M https://doi.org/10.1016/j.tibtech.2012.06.004>
13. 2019: Bacteria-targeted clindamycin loaded polymeric nanoparticles: Effect of surface charge on nanoparticle adhesion to MRSA, antibacterial activity, and wound healing. Pharmaceutics 11: 11050236
N, Cao J, Lee J, Hlaing SP, Oshi MA, Naeem M, Ki MH, Lee BL, Jung Y, Yoo JW
14. 2018: An antimicrobial peptide-loaded gelatin/chitosan nanofibrous membrane fabricated by sequential layer-by-layer electrospinning and electrospraying techniques. Nanomaterials 8: 327
< YZ, Jin YH, Wang XM, Yao SL, Li YY, Wu Q, Ma GW, Cui FZ, Liu HY https://doi.org/10.3390/nano8050327>
15. International Organization for Standardization, ISO 10993-5. Biological evaluation of medical services, Part 5: Tests for in vitro cytotoxicity. Geneva, Switzerland 2009.
16. 2018: Quantitative assessment of antimicrobial activity of PLGA films loaded with 4-hexylresorcinol. J Funct Biomater 9: 9010004
< M, Heinzel-Wieland R https://doi.org/10.3390/jfb9010004>
17. 2019: A review on mechanism of action, resistance, synergism, and clinical implications of mupirocin against Staphylococcus aureus. Biomed Pharmacother 109: 1809-1818
< S, Heidary M, Asadi A, Soleimani S, Motahar M, Savari M, Saki M, Abdi M https://doi.org/10.1016/j.biopha.2018.10.131>
18. 2022a: Poly(lactic-co-glycolic) acid nanoparticles as a delivery system for fish oil in wound healing. Acta Vet Brno 91: 285-291
< T, Popelková V, Košarišťanová L, Šmídová V https://doi.org/10.2754/avb202291030285>
19. 2022b: Effect of polymeric nanoparticles with entrapped fish oil or mupirocin on skin wound healing using a porcine model. Int J Mol Sci 23: 7663
< T, Sládek Z, Vícenová M, Simonová J, Franke G, Kacvinská K, Sabliov S, Astete CE, Levá L, Popelková V, Bátik A, Vojtová L https://doi.org/10.3390/ijms23147663>
20. 2018: Can disc diffusion susceptibility tests assess the antimicrobial activity of engineered nanoparticles? J Nanopart Res 20: 62
< A, Valenti M, van Rijn E, Beaumont HJE, Kalantzi OI, Schmidt-Ott A, Biskos G https://doi.org/10.1007/s11051-018-4152-3>
21. 2017: Development of chitosan/poly-gamma-glutamic acid/pluronic/curcumin nanoparticles in chitosan dressings for wound regeneration. J Biomed Mater Res B 105: 81-90
< YH, Lin JH, Hong YS https://doi.org/10.1002/jbm.b.33394>
22. 2013: Anthracycline nano-delivery systems to overcome multiple drug resistance: A comprehensive review. Nano Today 8: 313-331
< P, Mumper RJ https://doi.org/10.1016/j.nantod.2013.04.006>
23. 2022: High prevalence of heterogeneous mupirocin-resistent Staphylococcus aureus and its molecular characterization. Am J Translat Res 14: 8243-8251
E, Chen G, Liu R, Wang Y
24. 2020: Development of 3D printed drug-eluting scaffolds for preventing piercing infection. Pharmaceutics 12: 901
< E, Cartmell C, Saab M, Kerr RG, Ahmadi A https://doi.org/10.3390/pharmaceutics12090901>
25. 2022: Detection and distribution of low level and high level mupirocin resistance among clinical methicillin resistant Staphylococcus aureus isolates. J Clin Diagnos Res 16: DC06-DC10
PG, Kannan S, Appalaraju B
26. 2018: Preparation of antibacterial electrospun polylactic-co-glycolic acid nanofibers containing Hypericum perforatum with bedsore healing property and evaluation of tis drug release performance. Int J Nano Dimens 9: 286-297
F, Shariati S, Sohrabi M, Mahdavi H, Asadpour L
27. 2018: A review on nanoparticle based treatment for wound healing. J Drug Deliv Sci Technol 44: 421-430
< NK, Kumar SSD, Houreld NN, Abrahamse H https://doi.org/10.1016/j.jddst.2018.01.009>
28. 2020: Antibiotic delivery strategies to treat skin infections when innate antimicrobial defense fails. Antibiotics-Basel 9: 9020056
R, Russo J, Fiegel J, Brogden N
29. 2021: Formulation development of cream with mupirocin and essential oils for eradication of biofilm mediated antimicrobial resistance. Arch Microbiol 203: 1707-1715
< M, Karuppaiah A, Nithyanth M, Baberoselin R, Ramesh S, Geetha N, Veintramuthu S https://doi.org/10.1007/s00203-020-02175-5>
30. 2021: Recent advances and challenges in nanodelivery systems for antimicrobial peptides (AMPs). Antibiotics-Basel 10: 10080990
ZY, Ma QT, Chen XL, Chen TB, Ying Y, Xi XP, Wang L, Ma CB, Shaw C, Zhou M
31. 2011: PLGA nanoparticles loaded with the antileishmanial saponin β-aescin: Factor influence study and in vitro efficacy evaluation. Int J Pharm 420: 122-132
< H, Vermeersch M, Matheeussen A, Vandervoort J, Weyenberg W, Apers S, Cos P, Maes L, Ludwig A https://doi.org/10.1016/j.ijpharm.2011.08.016>
32. 2020: Synthesis of PLGA nanoparticles with entrapped antibiotic mupirocin. Proc Int PhD Stud Conf Mendel Net pp. 589-593
P, Popelkova V, Komprda T, Sabliov C, Astete CE